NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Rochester
St. Joseph's Hospital and Medical Center, Phoenix
University of Rochester
Vanderbilt-Ingram Cancer Center
Milton S. Hershey Medical Center
University of California, Los Angeles
Kythera Biopharmaceuticals